Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.890
-0.030 (-1.56%)
Jul 20, 2026, 3:59 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 189.66 million as of July 20, 2026. Its market cap has increased by 19.21% in one year.
Market Cap
189.66M
Enterprise Value
204.85M
Revenue
117.33M
Ranking
n/a
PE Ratio
17.46
Stock Price
1.89
ChartMarket Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 189.66M, a decrease of -10.37%. That is a compound annual growth rate of -1.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 189.66M | 14.75% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 388.33M |
| Auxly Cannabis Group | 258.04M |
| TerrAscend | 235.27M |
| Aurora Cannabis | 229.19M |
| Cardiol Therapeutics | 194.81M |
| Organigram Global | 175.97M |
| BioSyent | 165.86M |
| Medexus Pharmaceuticals | 160.84M |